ALLMedicine™ Anaphylaxis Center

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Jan 15th, 2022 - Silkworm pupa (SWP) food anaphylaxis has been described frequently in Asian countries. However, false-positive reactions by skin pricks and serum IgE (sIgE) tests to the extract complicate diagnosis, requiring identification of clinically relevant...

Jan 14th, 2022 - Primary Efficacy Objective: To demonstrate faster time to extubation after arrival in the cardiothoracic ICU in patients having a CABG who receive Sugammadex 2mg/kg as compared to placebo. Hypotheses: We hypothesize that the use of Sugammadex for ...

Jan 14th, 2022 - Contrast media agents are essential for computed tomography-based diagnoses. However, they can cause fatal adverse effects such as anaphylaxis in patients. Although it is rare, the chances of anaphylaxis increase with the number of examinations. T...

Jan 13th, 2022 - Sugammadex and neostigmine given to reverse residual neuromuscular blockade can cause side effects including bradycardia, anaphylaxis, bronchospasm, and even cardiac arrest. We tested the hypothesis that sugammadex is noninferior to neostigmine on...

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Jan 9th, 2021 - This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and...

May 23rd, 2020 - Anaphylaxis is a severe, potentially life-threatening acute allergic reaction that involves more than one system of the body.

Sep 3rd, 2019 - Our current recommendations for diagnosing and treating primary mast cell (MC) activation syndrome make use of the latest studies and consensus guidelines for clinically recognizing systemic anaphylaxis in real time, regardless of whether allergen...

Nov 18th, 2018 - Guideline review: Epinephrine use in anaphylaxis (AAP guideline 2017).|2018|Goodall N,|drug therapy,therapeutic use,therapeutic use,

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Jan 14th, 2022 - Primary Efficacy Objective: To demonstrate faster time to extubation after arrival in the cardiothoracic ICU in patients having a CABG who receive Sugammadex 2mg/kg as compared to placebo. Hypotheses: We hypothesize that the use of Sugammadex for ...

Dec 17th, 2021 - Subjects who meet all inclusion and no exclusion criteria after initial screening assessments will undergo a Skin Prick Test (SPT) followed by a baseline Double-Blind, Placebo-Controlled Food Challenge (DBPCFC) consisting of peanut and placebo (oa...

Nov 8th, 2021 - Study Design This was double-blinded randomized clinical trial that was conducted in Dr. Cipto Mangunkusumo National General Hospital in February - June 2021 after due permission from Ethics Committee of the Faculty of Medicine University of Indon...

Oct 27th, 2021 - Peanut allergy is a common allergy in the United States, with a prevalence in the general population as high as 1%. Peanut allergy management is based on strict peanut avoidance and injectable epinephrine after the allergic systemic reactions have...

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Jan 3rd, 2022 - Among people who reported an allergic reaction to sesame in a survey, more than half (56%) of the triggering foods did not declare sesame on the label. The findings were published online last month in Annals of Allergy, Asthma and Immunology. Some...

Dec 8th, 2021 - The FDA authorized a long-acting monoclonal antibody combination, tixagevimab-cilgavimab (Evusheld), to prevent COVID-19 in immunocompromised individuals and those with a history of a severe vaccine reaction, the agency said on Wednesday. In its e...

Dec 2nd, 2021 - The FDA approved the first three-antigen hepatitis B vaccine (PreHevbrio) to prevent infection from all known subtypes in adults, VBI Vaccines announced on Wednesday. Approval for the recombinant vaccine -- which contains the S, pre-S1, and pre-S2...

Nov 18th, 2021 - A randomised, double-blind, placebo-controlled, multicentre, phase 3 clinical trial has found that a new SARS-CoV-2 vaccine is “highly efficacious against laboratory-confirmed symptomatic COVID-19 disease”. Covaxin (code-named BBV152) is a whole v...